Antineoplastic and cytogenetic effects of complexes of Pd (II) with 4N-substituted derivatives of 2-acetyl-pyridine-thiosemicarbazone

Anticancer Research

Volumn 17, Issue 1 A, 1997, Pages 247-251

  Papageorgiou, A ^a   Iakovidou, Z ^b   Mourelatos, Denis ^b   Mioglou, E ^b   Boutis, L ^b   Kotsis, A ^b   Kovala Demertzi, D ^c   Domopoulou, A ^c   West, D X ^d   Dermetzis, M A ^c  

^a Theagenion Anticancer Institute   (Greece)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^c UNIVERSITY OF IOANNINA   (Greece)

^d ILLINOIS STATE UNIVERSITY   (United States)

Author keywords

Antileukemic activity; Cell kinetics; Pd(II) complexes; SCEs; Thiosemicarbazones

Indexed keywords

2 ACETYLPYRIDINE THIOSEMICARBAZONE; 3 HEXAMETHYLENEIMINYLTHIOSEMICARBAZONE; N4 ETHYLHEXAMETHYLENEIMINYLTHIOSEMICARBAZONE; PALLADIUM; THIOSEMICARBAZONE DERIVATIVE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL CULTURE; CELL DIVISION; CYTOGENETICS; DNA SYNTHESIS; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; LEUKEMIA L 1210; LEUKEMIA P 388; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SISTER CHROMATID EXCHANGE;

ANIMALS; ANTINEOPLASTIC AGENTS; DNA; FEMALE; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; ORGANOPLATINUM COMPOUNDS; SISTER CHROMATID EXCHANGE; STRUCTURE-ACTIVITY RELATIONSHIP; THIOSEMICARBAZONES;

EID: 0031043441     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Liberta AE, West DX: Antifungal and antitumour activity of heterocyclic thiosemicarbazones and their metal complexes. Biometals 5: 121-126, 1992.
2. French FA, Blanz JE: a-(N)-Formylheteroaromatic thiosemicarbazones. Inhibition of tumour-derived ribonucleoside diphosphate reduetase and correlation with in vivo antitumour activity. J Med Chem 17: 112-181, 1974.
3. Klayman DL, Scovill JP, Mason CJ, Bartosevich JF, Bruce J. Lin AJ: 2-Acetylpyridine thiosemicarbazones 6,2-acetylpyridine thisemicurbazones as antileukemic agents. Azhncim-Forsch/ Drug Res 33(II), 7: 909-912, 1983.
4. Levinson WE: Chelating substances. Antibiotics Chemother 27: 288-306, 1980.
5. Kovala-Demertzi D. Domopoulou A, Demertzis MA, Raptopoulou CP, Terzis A: Coordinating properties of 2-acetylpyridinethiosemicarbazone. Pd(II) complexes with neutral and deprotonated ligand. X-ray structure of bromo(2-acetyipyridincthiosemicarbazonato) palladium(II). Polyhedron 13: 1917-1925, 1994.
6. Tofilon PJ, Basic I, Milas L: Prediction of in vivo tumour response to the chemotherapeutic agents by the in vitro Sister Chromatid Exchange assay. Cancer Res 45: 2025-2030, 1985.
7. Deen DF, Kendall LE, Marton LJ, Tofilon PJ: Prediction of tumour cell chemosensitivity using the Sister Chromatid Exchange assay. Cancer Res 46: 1599-1602, 1986.
8. Mourelatos D, Dozi-Vassiliades J, Kotsis A, Gourtsas C: Enhancement of cytogenetic damage and of antineoplastic effect by caffeine in Ehrlich ascites tumour cells treated with cyclophosphamidc in vivo. Cancer Res 48: 1129-1131, 1988.
9. Eliopoulos P, Mourelatos D, Dozi-Vassiliades J: Comparative study on Salmonella mutagenicity and on cytogenetic and antineoplastic effects induced by cyclophosphamide and 3-aminobenzamide in cells of three transplantable tumours in vivo: Mutat Res 342: 141-146, 1995.
10. Abdel-Fadil MR, Palmer CG, Heerema E: Effect of temperature variation on SCEs and cell cycle duration in cultured human lymphocytes. Mutat Res 104: 267-273, 1982.
11. Klayman DL, Bartosevich JF, Griffith TS, Mason CJ, Scovill GP: 2-Acetylpyridinethiosemicarbazones. 1. A new class of potential antimalarial agents. J Med Chem 22: 855-862, 1979.
12. Scovill JP: Phosphorus, Sulfur and Silicon. 60: 15-19, 1991.
13. Goto K, Maeda S, Kano Y, Sugiyama T: Factors involved in the differential Giemsa-staining of sister chromadids. Chromosoma 66: 351-359, 1978.
14. Goldin A, Sofina Z, Syrkin A: National Cancer Inst Monograph (USA) No 55, 1980.